End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2799 USD | +1.82% |
|
+1.78% | -98.15% |
06-12 | Motion for Asset Sale Approved for Acorda Therapeutics, Inc. | CI |
05-14 | Acorda Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
348K | - | - | - | - | - | |
122B | ||||||
116B | ||||||
27.03B | - | |||||
20.36B | - | |||||
16.43B |